Australia's plain-English guide to medical imaging
About us  ·  Editorial policy
RadiologyScan All topics
Home  ›  Topics  ›  Contrast & dye  ›  MRI
Contrast & dye

MRI with contrast: when and why gadolinium is used

Some MRIs use a gadolinium contrast injection. Here's when it's needed, what it adds, and the safety points around kidneys, pregnancy and gadolinium retention.

RE
Written byRadiologyScan Editorial
Last reviewed 8 Jul 2026 5 min read
MRI with contrast: when and why gadolinium is used
Quick answer

Some MRIs use a gadolinium contrast injection to highlight certain tissues — for example to characterise a tumour, assess inflammation or look at blood vessels. Many common MRIs (brain, spine, joints) don't need it. Gadolinium is very safe and less likely to cause a reaction than iodine, but needs a kidney check if your kidney function is reduced, and is usually avoided in pregnancy.

 Key takeaways

  • Gadolinium contrast is used to highlight tumours, inflammation or blood vessels.
  • Many brain, spine and joint MRIs don't need it.
  • It's less likely to cause a reaction than iodine contrast.
  • It needs a kidney check if kidney function is reduced, and is avoided in pregnancy.

Some MRIs use a contrast injection to make certain tissues stand out. For MRI the contrast agent is gadolinium, which works by altering the magnetic behaviour of nearby water molecules — so the tissues holding it look different on the pictures.[1] Most of the time it isn’t needed, but when it is, it adds a lot.

When it’s used

Gadolinium is added when it will provide information the plain scan can’t — for example to characterise a tumour, assess inflammation or infection, or look at blood vessels.[2] Many of the most common MRIs — brain, spine and joint scans — often don’t need it.

How it’s given

If your MRI needs contrast, a small cannula is placed in a vein and the gadolinium is given during the scan. The dose is small, and it’s normal to feel a brief coolness at the injection site.[1]

Safety points

Gadolinium is generally very safe — and less likely to cause an allergic reaction than the iodine used for CT.[1] Two situations need care:

  • Reduced kidney function — in severe kidney disease, gadolinium carries a small risk of a condition called NSF (nephrogenic systemic fibrosis), so your kidney function is checked first and contrast may be avoided.[1]
  • Pregnancy — gadolinium is usually avoided (though the MRI itself can still be done if needed).[1]

Tell the team about any kidney problems, whether you could be pregnant, and any previous reaction to contrast.

What about gadolinium retention?

Tiny traces of gadolinium can be retained in the body, including the brain, after contrast MRI. There are no known harmful effects, but your doctor may factor it in when choosing an agent — especially for people who’ll have repeated MRIs.[1]

Frequently asked questions

Why do I need contrast for my MRI?

Because, for your particular question, it highlights something the plain scan can’t — such as a tumour, inflammation or blood vessels. Your radiologist decides if it’s needed.[2]

Is gadolinium safe?

Yes, for most people it’s very safe, and reactions are rarer than with iodine contrast. The main precautions are around reduced kidney function and pregnancy.[1]

Can I breastfeed after a gadolinium MRI?

Yes — guidance from the ACR concludes it’s safe to keep breastfeeding, as only a tiny amount reaches the milk. You can express and discard for 24 hours if you prefer, but it isn’t required.[1]

About this article. General information only — not personal medical advice; always follow the guidance of your own doctor or imaging centre. Last reviewed 8 Jul 2026. See our editorial & review policy.

Sources

  1. RadiologyInfo.org (RSNA & ACR) — Contrast Materials — www.radiologyinfo.org/en/info/safety-contrast
  2. RANZCR / InsideRadiology — Magnetic resonance imaging (MRI) — www.insideradiology.com.au/mri-hp/
RE

RadiologyScan Editorial

Written and edited by RadiologyScan Editorial

Our articles are written in plain English and fact-checked against Australian clinical sources. How we work →